Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

"This is an interesting review of important technologies for identifying different cancers. Nevisense represents an innovative approach to enhancing early-stage melanoma detection while minimizing ...

The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

The company announced interim data showing strong systemic responses in its safety and efficacy study combining Alpha DaRT treatment with ...

McDermott says that he started seeing a dermatologist when he was in his 20s at the recommendation of his parents.

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of ...

Barcelona-based Sycai Medical has closed a €3M funding round backed by LUMO Labs, Ship2B Ventures, Athos Capital, and Namarel Ventures.